Impact of Patient Reported Outcomes for Pre-chemotherapy Medical Decision in Day Patients With Digestive Cancer

Study Overview
=================
Brief Summary
-----------------
The investigators hypothesize that an early assessment of the clinical toxicity of the patient is possible via patient reported outcomes and that this information provides at least the same information level as the clinical examination of the patient made by the doctor. The early decision to prepare chemotherapy medications based on the indirect early collection of clinical information from the patient via a patient reported outcome should help minimize the number of chemotherapy medications destroyed.

Official Title
-----------------
Impact of Patient Reported Outcomes for Pre-chemotherapy Medical Decision in Day Patients With Digestive Cancer

Conditions
-----------------
Digestive Cancer

Intervention / Treatment
-----------------
* Other: Patient Reported Outcome questionnaire


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: The patient must have given their free and informed consent and signed the consent form The patient must be a member or beneficiary of a health insurance plan Patient is undergoing at least their second chemotherapy regime (outside weekly scheme or protocol with cisplatin requiring hospitalization) for a digestive tumor Patient has a Smartphone or access to the internet (via tablet or computer) The patient is under consultation as a day patient in the Oncology Department of Nimes hosptial Exclusion Criteria: The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study The subject refuses to sign the consent It is impossible to give the subject informed information The patient is under safeguard of justice or state guardianship The patient is pregnant, parturient or breastfeeding Patient has already participated in the study Patient undergoing first chemotherapy regime

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients undergoing chemotherapy<br> | Other: Patient Reported Outcome questionnaire<br>* 34 question form to assess patient symptoms<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Authorization for preparation of chemotherapy based on clinical information (decision 2) | Yes/no | Day 1 | 
| Authorization for preparation of chemotherapy based on patient reported outcome (decision 3) | Yes/no | Day 1 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Cost of unused pouches of prepared chemotherapy according to decisions | Euros | Day 1 | 
| Authorization for preparation of chemotherapy based on biological results (decision 1) | Yes/no | Day 0 | 
| Patient satisfaction with the patient reported outcome questionnaire | System Usability Scale (SUS); score between 0-100 where the higher the score, the more satisfied the patient is. | Before starting chemotherapy (Up to 72 hours prior to treatment starting) |